Drug Reference
Amprenavir
Protease inhibitors
Fact box
- Therapeutic class
- Protease inhibitors
- Action class
- Protease Inhibitor
- Mechanism
- HIV Protease Inhibitors
- Habit forming
- No
Available as
50 MG · Oral Capsule150 MG · Oral Capsule15 MG/ML · Oral Solution
No structured FDA label was available. Use the authoritative links below.
Current FDA labels (DailyMed)
- FOSAMPRENAVIR CALCIUM TABLET, COATED [SUN PHARMACEUTICAL INDUSTRIES, INC.]
- FOSAMPRENAVIR CALCIUM TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.]
- LEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]
- LEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.